PUNE, India, April 25, 2018 /PRNewswire/ --
According to a new market research report "In Vitro Lung Model Marketby Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023", published by MarketsandMarkets™,
(Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )
Browse 42 market data Tables and 0 Figures spread through 100 Pages and in-depth TOC on "In Vitro Lung Model Market"
Early buyers will receive 10% customization on this report
2D models are expected to account for the largest share of the lung In Vitro Models Market in 2018
Based on type, the market is segmented into 2D cell models and 3D cell models. The 2D models segment is expected to account for the largest share of the market owing to its use historically. Additionally, 2D models/cell lines are used in the research and development of 3D models. However, the 3D cell models segment is projected to grow at the fastest rate during the forecast period owing to the rising need for efficient lung in vitro models that mimic in vivo physiology.
The drug discovery and toxicology applications of 3D models are expected to grow at the highest CAGR during the forecast period
Based on application, the market is segmented applications of 2D models and 3D models. Applications of 3D models include drug discovery and toxicology, physiological research, and stem cell research & regenerative medicine. The drug discovery and toxicology segment is also expected grow at the highest CAGR during the forecast period owing to increasing adoption of 3D models in this area.
Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=78042820
North America to command the largest share of the lung In Vitro Models Market in 2018
North America held the largest share of the lung In Vitro Models Market in 2017. Flourishing research environment and abundant funding programs from organizations such as the National Institutes of Health (NIH) and increased R&D activities by biotechnology and pharmaceutical companies are driving the growth of the lung In Vitro Models Market in North America.
The major players in the Lung In Vitro Models Market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).
Know more about the In Vitro Lung Model Market:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact: Mr. Salgarkar MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: email@example.com
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
Subscribe to our Free Newsletters!
Lofexidine tablets for oral use were approved by FDA in May 2018, for reducing the intensity of ...
Tularemia is an uncommon, highly contagious bacterial infection acquired in humans by insect bites ...
Nipah Virus (NiV) or Hendra virus is a deadly virus that spreads via contact with the saliva, ...View All